Skip to main contentSkip to navigation
Sirius Investors
Aoxing Pharmaceutical Company, Inc.

Aoxing Pharmaceutical Company, Inc.

AOXG
OTCHealthcare

AOXG Financial Statements & Analysis

Complete financial statements for AOXG including income statement, balance sheet, and cash flow statement. Analyze AOXG's revenue growth, profit margins, earnings trends, debt levels, and cash flow generation.

Income Statement Comparison

Revenue & Net Income

Period Comparison

Metric20242025ChangeImpact
Revenue000.0%
Gross Profit000.0%
Operating Income-14.82K-7.30K50.7%
Net Income-14.82K55.24K472.6%
EPS-0.000.00330.2%
EBITDA-14.82K55.24K472.7%
Gross Margin0.00%0.00%0.0%
Operating Margin0.00%0.00%0.0%
Net Income Margin0.00%0.00%0.0%
R&D Expenses000.0%

Income Statement Full Table

Free users can view the last 3 periods. Upgrade to see the full history.

Upgrade
Metric20252024
Revenue00
Gross Profit00
Operating Income-7.30K-14.82K
Net Income55.24K-14.82K
EPS0.00-0.00
EBITDA55.24K-14.82K
Gross Margin0.00%0.00%
Operating Margin0.00%0.00%
Net Income Margin0.00%0.00%
R&D Expenses00

Our detailed financial analysis helps investors understand AOXG's business performance, operational efficiency, and financial health through comprehensive financial statement data presented in both quarterly and annual formats.

Track AOXG's financial performance metrics including revenue, gross profit, operating income, net income, total assets, liabilities, shareholders' equity, operating cash flow, and free cash flow with historical comparison and trend analysis.

Financial Metrics

Want to dive deeper into AOXG's financial health? Explore key financial metrics and ratios including profitability, liquidity, efficiency, and valuation metrics.

View Financial Metrics